Table 4 |
|||||
|
Percentage (95% CI) of respondents rating each type of medication as "helpful" for the person described in the vignette |
|||||
|
Medication |
Country |
Depression Vignette |
Depression/Suicidal Vignette |
Early Schizophrenia Vignette |
Chronic Schizophrenia Vignette |
|
|
|||||
|
Vitamins, minerals |
Australia |
50.2 (45.4–55.1) |
43.7 (39.2–48.3) |
31.3 (27.4–35.5) |
33.2 (28.9–37.8) |
|
Japan |
20.2 (16.7–23.7) |
16.4 (13.1–19.7) |
10.6 (7.9–13.3) |
12.4 (9.5–15.3) |
|
|
Pain relievers |
Australia |
14.8 (11.7–18.5) |
12.3 (9.6–15.7) |
7.3 (5.3–9.9) |
10.2 (7.7–13.4) |
|
Japan |
4.4 (2.6–6.2) |
3.6 (2.0–5.2) |
4.2 (2.4–6.0) |
4.6 (2.8–6.4) |
|
|
Antidepressants |
Australia |
46.7 (42.4–51.1) |
52.5 (48.1–56.7) |
49.9 (45.7–54.2) |
42.6 (37.9–47.5) |
|
Japan |
34.8 (30.6–39.0) |
36.0 (31.8–40.2) |
38.6 (34.3–42.9) |
39.8 (35.5–44.1) |
|
|
Antibiotics |
Australia |
10.4 (7.9–13.7) |
7.9 (5.7–10.8) |
4.0 (2.5–6.2) |
6.4 (4.5–9.1) |
|
Japan |
6.2 (4.1–8.3) |
6.0 (3.9–8.1) |
4.8 (2.9–6.7) |
8.4 (6.0–10.8) |
|
|
Sleeping pills |
Australia |
23.9 (20.1–28.1) |
21.9 (18.6–25.6) |
18.1 (14.7–22.1) |
11.6 (8.8–15.1) |
|
Japan |
31.6 (27.5–35.7) |
26.2 (22.3–30.1) |
21.4 (17.8–25.0) |
24.8 (21.0–28.6) |
|
|
Antipsychotics |
Australia |
11.2 (8.4–14.8) |
16.5 (13.3–20.3) |
33.1 (29.0–37.5) |
38.2 (34.0–42.6) |
|
Japan |
22.6 (18.9–26.3) |
21.8 (18.2–25.4) |
30.2 (26.2–34.2) |
41.2 (36.9–45.5) |
|
|
Tranquillizers |
Australia |
13.8 (11.0–17.1) |
13.8 (11.0–17.1) |
17.2 (14.1–20.8) |
15.3 (12.6–18.4) |
|
Japan |
38.4 (34.1–42.7) |
37.0 (32.8–41.2) |
38.4 (34.1–42.7) |
45.4 (41.0–49.8) |
|
|
|
|||||
|
Jorm et al. BMC Medicine 2005 3:12 doi:10.1186/1741-7015-3-12 |
|||||
